We are live on ! Find out more
EMR

Errol M. Rudman Portfolio holdings

AUM $148M Turnover 10%
1-Year Est. Return 19.65%
This Fund
S&P 500
This Quarter Est. Return
+7.38%
1 Year Est. Return
+19.65%
3 Year Est. Return
+60.53%
5 Year Est. Return
+120.34%
10 Year Est. Return
–
AUM
$206M
AUM Growth
+$32M
Cap. Flow
+$18.5M
Cap. Flow %
8.96%
Top 10 Hldgs %
56.47%
Holding
45
New
11
Increased
6
Reduced
2
Closed
3
Avg Time Held
1.6 years
Top 10 Avg Time Held
1.9 years
Top 20 Avg Time Held
2.1 years

Top Buys

Rank Stock Value
1
LUMN icon
Lumen Technologies, Inc. Common Stock
LUMN
+$6.19M
2
SHW icon
Sherwin-Williams
SHW
+$5.92M
3
GE icon
GE Aerospace
GE
+$3.98M
4
MCK icon
McKesson
MCK
+$2.96M
5
XRAY icon
Dentsply Sirona
XRAY
+$2.54M

Top Sells

Rank Stock Value
1
LVLT
Level 3 Communications Inc
LVLT
+$14.3M
2
UAL icon
United Airlines
UAL
+$1.04M
3
TEVA icon
Teva Pharmaceutical Industries Limited
TEVA
+$880K
4
THC icon
Tenet Healthcare
THC
+$411K
5
TDG icon
TransDigm Group
TDG
+$99.2K

Sector Composition

Rank Sector Weight
1 Industrials 30.82%
2 Healthcare 25.68%
3 Consumer Discretionary 9.78%
4 Financials 8.92%
5 Materials 7.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
XBI icon
26
State Street SPDR S&P Biotech ETF
XBI
$9.79B
$2.55M 1.23%
30,000
– –
2017 Q2
2 quarters
IBB icon
27
iShares Biotechnology ETF
IBB
$10.5B
$2.4M 1.16%
22,500
– –
2017 Q2
2 quarters
ENTG icon
28
Entegris
ENTG
$21.9B
$2.35M 1.14%
77,291
– –
2017 Q1
3 quarters
CBPO
29
DELISTED
China Biologic Products Holdings, Inc.
CBPO
$2.26M 1.1%
28,701
+1,800
+7% +$150K
2014 Q2
14 quarters
SEE icon
30
DELISTED
Sealed Air
SEE
$1.97M 0.96%
40,000
– –
2017 Q2
2 quarters
MDB icon
31
MongoDB
MDB
$29.1B
$1.96M 0.95%
+66,000
New +$1.93M
2017 Q4
0 quarters
CGNX icon
32
Cognex
CGNX
$9.24B
$1.83M 0.89%
30,000
– –
2017 Q2
2 quarters
CALM icon
33
Cal-Maine
CALM
$2.99B
$1.78M 0.86%
+40,000
New +$1.78M
2017 Q4
0 quarters
ASML icon
34
ASML
ASML
$641B
$1.74M 0.84%
10,000
– –
2017 Q2
2 quarters
JPM icon
35
JPMorgan Chase
JPM
$911B
$1.71M 0.83%
+16,000
New +$1.62M
2017 Q4
0 quarters
C icon
36
Citigroup
C
$212B
$1.49M 0.72%
+20,000
New +$1.48M
2017 Q4
0 quarters
TMO icon
37
Thermo Fisher Scientific
TMO
$257B
$1.42M 0.69%
7,500
– –
2013 Q4
16 quarters
CCMP
38
DELISTED
CMC Materials, Inc. Common Stock
CCMP
$1.22M 0.59%
13,000
– –
2016 Q3
5 quarters
UGL icon
39
ProShares Ultra Gold
UGL
$724M
$1.2M 0.58%
118,000
– –
2017 Q1
3 quarters
HSIC icon
40
Henry Schein
HSIC
$9.72B
$1.05M 0.51%
+19,125
New +$1.11M
2017 Q4
0 quarters
BCS icon
41
Barclays
BCS
$77.4B
$981K 0.48%
+94,139
New +$914K
2017 Q4
0 quarters
WFC icon
42
Wells Fargo
WFC
$253B
$910K 0.44%
+15,000
New +$847K
2017 Q4
0 quarters
TEVA icon
43
Teva Pharmaceutical Industries Limited
TEVA
$48.1B
– –
-50,000
Closed -$880K –
THC icon
44
Tenet Healthcare
THC
$22.1B
– –
-25,000
Closed -$411K –
LVLT
45
DELISTED
Level 3 Communications Inc
LVLT
– –
-268,417
Closed -$14.3M –
1
2

Similar funds

HAM
Hillswick Asset Management Stamford, Connecticut $150M AUM 7.89% 1-Year Est. Return
TAM
Taylor Asset Management Toronto, Ontario, Canada $154M AUM 10.32% 1-Year Est. Return
RMPT
Raytheon Master Pension Trust Waltham, Massachusetts $140M AUM 5.65% 1-Year Est. Return
QAM
Quantres Asset Management Cayman, Cayman Islands $138M AUM 11.79% 1-Year Est. Return
CWM
Catamount Wealth Management Westport, Connecticut $176M AUM 15.01% 1-Year Est. Return
RCA
Restructuring Capital Associates Stamford, Connecticut $115M AUM 20.18% 1-Year Est. Return
CI
Caerus Investors New York $183M AUM 0.18% 1-Year Est. Return
LS
Lattice Strategies Wayne, Pennsylvania $109M AUM 3.52% 1-Year Est. Return

Errol M. Rudman's Q4 2017 Portfolio in Review

As of Q4 2017, Errol M. Rudman held 45 positions worth $206M, up 18% from $174M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Errol M. Rudman deployed $18.5M of net new capital in Q4 2017, opening 11 new positions and adding to 6 existing holdings. Its largest new stake was Lumen Technologies, Inc. Common Stock: 364,841 shares worth $6.09M.

By sector, the portfolio is most concentrated in Industrials at 31% of assets, down from 40% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was United Airlines, an estimated $1.04M trimmed.

  • Errol M. Rudman's largest Q4 2017 buy was Lumen Technologies, Inc. Common Stock: 364,841 shares worth $6.09M.
  • Errol M. Rudman added most to Dentsply Sirona in Q4 2017, an estimated $2.54M increase.
  • Errol M. Rudman's biggest Q4 2017 reduction was United Airlines, cutting an estimated $1.04M.
  • Errol M. Rudman fully exited Level 3 Communications Inc in Q4 2017, selling an estimated $14.3M.
  • Errol M. Rudman's ten largest holdings make up 56% of its $206M portfolio in Q4 2017.
  • Errol M. Rudman opened 11 new positions and closed 3 in Q4 2017.
  • Errol M. Rudman's portfolio value rose 18% quarter-over-quarter to $206M.

Based on Errol M. Rudman's 13F filing for Q4 2017, filed 14 Feb 2018.